Quince Therapeutics

QNCX

Market cap $159M

2.78 USD

-0.08

2.8%

At close Updated Jan 6, 4:00 PM EST

Pre-market

After hours

2.85

+0.07

2.52%

1 day

-2.8%

5 days

-17.75%

1 month

-28.72%

3 months

42.56%

6 months

70.55%

Year to date

-7.33%

1 year

39.7%

5 years

-90.67%

10 years

-91.55%

About: Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.

Employees: 36

Healthcare Biotechnology